A Study of BGM0504 in Early T2DM With Obesity

Clinical trial NCT07743983 · RECRUITING

Trial details

NCT number: NCT07743983
Sponsor: BrightGene Bio-Medical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes (T2DM)

Start date: 2026-08-30
Primary completion: 2028-09-30
Enrollment: 372

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.